Additional side-effect monitoring is no longer required...
Canagliflozin, dapagliflozin and empagliflozin have...
GPs and MIMS subscribers can now view images and key...
Xadago (safinamide) is the first new drug for Parkinson's...
MIMS Learning users who subscribe to the Clarity &...
New and deleted products
Latest CPD from MIMS Learning
Summary of NICE guidance on treatment of type 2 diabetes.
Instructions for changing or stopping antidepressants.
Hormone doses and costs of HRT preparations.
Types, presentations and profiles of insulin products.
Summary of NICE guidance on menopause.
At-a-glance list of potential sensitising agents in emollients.
Summary of NICE advice on OA diagnosis, treatment and referral.
New products coming soon to MIMS
Check back soon to find MIMS listings for the following new drugs:
Coagadex (human coagulation factor X)
Elocta (efmoroctocog alfa)
Feraccru (ferric maltol)
Fertavid (follitropin beta)
Idelvion (albutrepenonacog alfa)
Often misdiagnosed, these conditions can have a significant...
Dr John Mckenna describes the principles of Mohs surgery...
The time is right for practitioners performing aesthetic...
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS.
Handy calculators and conversions for primary care.